American Well [AMWL] vs Sophia Genetics SA [SOPH] Detailed Stock Comparison
American Well
NYSE
Loading...
Sophia Genetics SA
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 18 vital metrics comparison: American Well wins in 10 metrics, Sophia Genetics SA wins in 8 metrics, with 0 ties. American Well appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | American Well | Sophia Genetics SA | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -0.50 | -3.41 | Sophia Genetics SA |
| Price-to-Book Ratio | 0.40 | 2.85 | American Well |
| Debt-to-Equity Ratio | 2.17 | 83.21 | American Well |
| PEG Ratio | 0.01 | -0.08 | Sophia Genetics SA |
| EV/EBITDA | 0.92 | -2.85 | Sophia Genetics SA |
| Profit Margin (TTM) | -46.16% | -105.32% | American Well |
| Operating Margin (TTM) | -28.74% | -100.92% | American Well |
| Return on Equity | -37.62% | -74.09% | American Well |
| Return on Assets (TTM) | -17.93% | -23.46% | American Well |
| Free Cash Flow (TTM) | $-142.56M | $-51.00M | Sophia Genetics SA |
| 1-Year Return | -11.98% | -13.60% | American Well |
| Price-to-Sales Ratio (TTM) | 0.42 | 3.14 | American Well |
| Enterprise Value | $-87.96M | $187.95M | Sophia Genetics SA |
| EV/Revenue Ratio | -0.33 | 2.70 | American Well |
| Gross Profit Margin (TTM) | 56.07% | 66.97% | Sophia Genetics SA |
| Revenue per Share (TTM) | $17 | $1 | American Well |
| Earnings per Share (Diluted) | $-8.03 | $-1.10 | Sophia Genetics SA |
| Beta (Stock Volatility) | 1.28 | 1.02 | Sophia Genetics SA |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
American Well vs Sophia Genetics SA Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| American Well | 3.87% | 1.16% | -17.69% | 0.87% | -20.23% | -0.85% |
| Sophia Genetics SA | -4.99% | -6.36% | -5.26% | 6.23% | 4.18% | 1.57% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| American Well | -11.98% | -91.94% | -98.48% | -98.48% | -98.48% | -98.48% |
| Sophia Genetics SA | -13.60% | 5.19% | -80.67% | -80.67% | -80.67% | -80.67% |
Performance & Financial Health Analysis: American Well vs Sophia Genetics SA
| Metric | AMWL | SOPH |
|---|---|---|
| Market Information | ||
| Market Cap | $112.74M | $218.96M |
| Market Cap Category | Micro cap | Micro cap |
| 10 Day Avg. Volume | 58,190 | 44,660 |
| 90 Day Avg. Volume | 63,940 | 76,097 |
| Last Close | $6.98 | $3.24 |
| 52 Week Range | $6.09 - $12.95 | $2.58 - $4.92 |
| % from 52W High | -46.10% | -34.15% |
| All-Time High | $875.00 (Jan 25, 2021) | $19.80 (Aug 30, 2021) |
| % from All-Time High | -99.20% | -83.64% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.13% | 0.16% |
| Quarterly Earnings Growth | 0.13% | 0.16% |
| Financial Health | ||
| Profit Margin (TTM) | -0.46% | -1.05% |
| Operating Margin (TTM) | -0.29% | -1.01% |
| Return on Equity (TTM) | -0.38% | -0.74% |
| Debt to Equity (MRQ) | 2.17 | 83.21 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $17.56 | $1.14 |
| Cash per Share (MRQ) | $13.56 | $1.40 |
| Operating Cash Flow (TTM) | $-75,621,000 | $-36,724,000 |
| Levered Free Cash Flow (TTM) | $-16,141,000 | $-21,213,750 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: American Well vs Sophia Genetics SA
| Metric | AMWL | SOPH |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -0.50 | -3.41 |
| Forward P/E | -0.91 | -4.00 |
| PEG Ratio | 0.01 | -0.08 |
| Price to Sales (TTM) | 0.42 | 3.14 |
| Price to Book (MRQ) | 0.40 | 2.85 |
| Market Capitalization | ||
| Market Capitalization | $112.74M | $218.96M |
| Enterprise Value | $-87,956,408 | $187.95M |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | -0.33 | 2.70 |
| Enterprise to EBITDA | 0.92 | -2.85 |
| Risk & Other Metrics | ||
| Beta | 1.28 | 1.02 |
| Book Value per Share (MRQ) | $17.56 | $1.14 |
Financial Statements Comparison: American Well vs Sophia Genetics SA
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | AMWL | SOPH |
|---|---|---|
| Revenue/Sales | $66.83M | $18.32M |
| Cost of Goods Sold | $31.57M | $6.05M |
| Gross Profit | $35.26M | $12.27M |
| Research & Development | $22.10M | $8.49M |
| Operating Income (EBIT) | $-30.41M | $-18.49M |
| EBITDA | $-33.32M | $-15.70M |
| Pre-Tax Income | $-17.01M | $-21.65M |
| Income Tax | $568,000 | $762,000 |
| Net Income (Profit) | $-18.36M | $-22.41M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | AMWL | SOPH |
|---|---|---|
| Cash & Equivalents | $222.41M | $68.53M |
| Total Current Assets | $311.50M | $90.05M |
| Total Current Liabilities | $106.73M | $28.94M |
| Long-Term Debt | $3.57M | $27.84M |
| Total Shareholders Equity | $305.77M | $85.61M |
| Retained Earnings | $-1.98B | $-457.66M |
| Property, Plant & Equipment | $6.72M | $4.99M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | AMWL | SOPH |
|---|---|---|
| Operating Cash Flow | $-5.33M | $-11.17M |
| Capital Expenditures | $-9,000 | $0 |
| Free Cash Flow | $-25.12M | $-12.24M |
| Debt Repayment | N/A | $-463,000 |
| Common Stock Repurchase | $-1,000 | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | AMWL | SOPH |
|---|---|---|
| Shares Short | 162,811 | 40,888 |
| Short Ratio | 2.19 | 0.53 |
| Short % of Float | 0.01% | 0.00% |
| Average Daily Volume (10 Day) | 58,190 | 44,660 |
| Average Daily Volume (90 Day) | 63,940 | 76,097 |
| Shares Outstanding | 15.57M | 66.69M |
| Float Shares | 12.35M | 50.71M |
| % Held by Insiders | 0.06% | 0.06% |
| % Held by Institutions | 0.44% | 0.48% |
Dividend Analysis & Yield Comparison: American Well vs Sophia Genetics SA
| Metric | AMWL | SOPH |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |